Business Description
CROSSJECT
ISIN : FR0011716265
Total Employee Number:
103Compare
Compare
Traded in other countries / regions
ALCJ.France74C.Germany IPO Date
2017-06-01Description
CROSSJECT manufactures and markets needle-free drug self-injection system.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | -0.16 | |||||
Debt-to-Equity | -4.61 | |||||
Debt-to-EBITDA | -3.71 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 22 | |||||
3-Year EPS without NRI Growth Rate | 12.9 | |||||
3-Year FCF Growth Rate | 18.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.65 | |||||
9-Day RSI | 35.44 | |||||
14-Day RSI | 38.07 | |||||
3-1 Month Momentum % | -3.35 | |||||
6-1 Month Momentum % | -7.67 | |||||
12-1 Month Momentum % | 33.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.51 | |||||
Days Inventory | 126.69 | |||||
Days Payable | 165.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.8 | |||||
Shareholder Yield % | -2.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -33.31 | |||||
ROIC % | -46.77 | |||||
3-Year ROIIC % | 174.42 | |||||
ROC (Joel Greenblatt) % | -183.87 | |||||
ROCE % | -50.21 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 10.59 | |||||
EV-to-EBIT | -10.66 | |||||
EV-to-EBITDA | -20.72 | |||||
EV-to-FCF | -11.55 | |||||
Price-to-GF-Value | 1.51 | |||||
Earnings Yield (Greenblatt) % | -9.38 | |||||
FCF Yield % | -10.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CROSSJECT Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.201 | ||
| Beta | 0.7527 | ||
| 3-Year Sharpe Ratio | -0.04 | ||
| 3-Year Sortino Ratio | -0.06 | ||
| Volatility % | 56.81 | ||
| 14-Day RSI | 38.07 | ||
| 14-Day ATR (€) | 0.069502 | ||
| 20-Day SMA (€) | 1.8523 | ||
| 12-1 Month Momentum % | 33.83 | ||
| 52-Week Range (€) | 1.364 - 2.645 | ||
| Shares Outstanding (Mil) | 59.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CROSSJECT Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CROSSJECT Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CROSSJECT Frequently Asked Questions
What is CROSSJECT(STU:74C)'s stock price today?
The current price of STU:74C is €1.78. The 52 week high of STU:74C is €2.65 and 52 week low is €1.36.
When is next earnings date of CROSSJECT(STU:74C)?
The next earnings date of CROSSJECT(STU:74C) is .
Does CROSSJECT(STU:74C) pay dividends? If so, how much?
CROSSJECT(STU:74C) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CROSSJECT
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers